DK1458417T3 - Fremgangsmåde til inaktivering af bakterier og leukocyter i thrombocyt-suspensioner - Google Patents

Fremgangsmåde til inaktivering af bakterier og leukocyter i thrombocyt-suspensioner

Info

Publication number
DK1458417T3
DK1458417T3 DK02795020T DK02795020T DK1458417T3 DK 1458417 T3 DK1458417 T3 DK 1458417T3 DK 02795020 T DK02795020 T DK 02795020T DK 02795020 T DK02795020 T DK 02795020T DK 1458417 T3 DK1458417 T3 DK 1458417T3
Authority
DK
Denmark
Prior art keywords
leukocytes
inactivating bacteria
platelet suspensions
suspensions
inactivating
Prior art date
Application number
DK02795020T
Other languages
English (en)
Inventor
Harald Mohr
Original Assignee
Blutspendedienst Dt Rote Kreuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst Dt Rote Kreuz filed Critical Blutspendedienst Dt Rote Kreuz
Application granted granted Critical
Publication of DK1458417T3 publication Critical patent/DK1458417T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK02795020T 2001-12-19 2002-12-18 Fremgangsmåde til inaktivering af bakterier og leukocyter i thrombocyt-suspensioner DK1458417T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10162712A DE10162712A1 (de) 2001-12-19 2001-12-19 Verfahren zur Inaktivierung von Bakterien und Leukozyten in Blut oder Blutprodukten

Publications (1)

Publication Number Publication Date
DK1458417T3 true DK1458417T3 (da) 2005-12-12

Family

ID=7710006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02795020T DK1458417T3 (da) 2001-12-19 2002-12-18 Fremgangsmåde til inaktivering af bakterier og leukocyter i thrombocyt-suspensioner

Country Status (10)

Country Link
US (1) US20050009913A1 (da)
EP (1) EP1458417B1 (da)
AT (1) ATE308345T1 (da)
AU (1) AU2002360911B2 (da)
CA (1) CA2470267A1 (da)
CY (1) CY1105671T1 (da)
DE (2) DE10162712A1 (da)
DK (1) DK1458417T3 (da)
ES (1) ES2250734T3 (da)
WO (1) WO2003051404A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2857264A1 (fr) * 2003-07-09 2005-01-14 Maco Pharma Sa Procede d'inactivation photodynamique des pathogenes au moyen d'ala
DE102005009479A1 (de) * 2005-03-02 2006-09-07 Molzym Gmbh & Co. Kg Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden
DE102006014184A1 (de) * 2006-03-24 2007-09-27 Heim, Heidrun Verfahren zum Inaktivieren von in Blutplasma unerwünschten Organismen, insbesondere von Viren
DE102015109277A1 (de) * 2015-06-11 2016-12-15 Infineon Technologies Ag Strommessung
WO2017205877A1 (en) * 2016-05-27 2017-11-30 Bloodworks Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI951295A7 (fi) * 1992-09-21 1995-05-17 Quadra Logic Tech Inc Ihon läpi tapahtuva veressä olevien valoherkkien aineiden in vivo-akti vointi
ATE189966T1 (de) * 1992-11-20 2000-03-15 Univ British Columbia Aktivierung von photoempfindlichen mitteln
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
US6277337B1 (en) * 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers

Also Published As

Publication number Publication date
DE50204805D1 (de) 2005-12-08
WO2003051404A1 (de) 2003-06-26
WO2003051404A8 (de) 2003-11-06
CY1105671T1 (el) 2010-12-22
AU2002360911A1 (en) 2003-06-30
CA2470267A1 (en) 2003-06-26
ATE308345T1 (de) 2005-11-15
DE10162712A1 (de) 2003-07-17
ES2250734T3 (es) 2006-04-16
EP1458417A1 (de) 2004-09-22
AU2002360911B2 (en) 2007-06-28
US20050009913A1 (en) 2005-01-13
EP1458417B1 (de) 2005-11-02

Similar Documents

Publication Publication Date Title
NO20061013L (no) Bisykliske imidazolderivater mot flaviviridae
BRPI0514017A (pt) indazóis úteis no tratamento de doenças cardiovasculares
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
NO20065178L (no) Tienopyridinderivater
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
SE0202241D0 (sv) Novel Compounds
DE50310516D1 (de) Fredericamycin-derivate
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
CY1107274T1 (el) Παραγωγα αλφα-αμινοαμιδιου χρησιμα σαν παραγοντες κατα της ημικρανιας
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
CY1107774T1 (el) Διαχωρισμος των ισομερων θεσης των φθαλοκυανινων μεταλλων
DK1362045T3 (da) 2-Thio-substituerede imidazolderivater og deres anvendelse inden for farmacien
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DK1458417T3 (da) Fremgangsmåde til inaktivering af bakterier og leukocyter i thrombocyt-suspensioner
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
NO20032406D0 (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren
ATE346040T1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
NO20030500L (no) Dihydroporfyrinderivater og deres anvendelse
DE602004030330D1 (de) KRISTALLSTRUKTUR DER TRYPANOSOMA CRUZI PROLINE RACEMASE (TcPRACA) UND VERWENDUNG DAVON
DK1307241T3 (da) Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension
ATE364037T1 (de) Tryptasehemmer
CY1114194T1 (el) Αναστολεις δραστικοτητας ακτ
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf
SE0301796D0 (sv) New use II